The anticancer properties of Trp derivatives can also be seen in methyl-Trp derivatives and IDO inhibitors which are potential medicines for treating tumor development and metastasis formation due to IDO-related immune tolerance for cancer antigens. This evidence concerns the gene IDO1 and neoplasm.